Supplier News

The latest developments from suppliers of ingredients, development and manufacturing services, and related technologies for pharmaceutical and biopharmaceutical development and production.

Oxford Genetics, an Oxford, England-headquartered synthetic biology-based technology company, has signed an agreement with MeiraGTx, a London, UK-based clinical-stage gene therapy company, to develop adeno-associated virus (AAV) vectors as well as...

Abzena, a contract manufacturer of biologics and antibody drug conjugates, has entered into a master services agreement with an undisclosed US biotechnology company to provide process development and manufacturing services to progress an...

WuXi Biologics, part of WuXi AppTec, a contract service provider, has opened its cGMP biologics manufacturing facility in Wuxi, China for full operations. In April 2015, WuXi Biologics announced a $150-million investment to build a biologics...

Wasdell, a Newcastle, UK-headquartered packaging company, plans to build a pharmaceutical packaging facility in Dundalk, Ireland. Wasdell says the facility will provide offer quality-control import testing, a variety of current and novel packaging...

Catalent Pharma Solutions and Vaccinex, a Rochester, New York-headquartered clinical-stage biotechnology company, have signed an agreement to develop an antibody-drug conjugate (ADC). The companies plan to use Catalent’s proprietary SMARTag...

Mustang Bio, a New York-headquartered clinical-stage biopharmaceutical company and a subsidiary of the biopharmaceutical company, Fortress Biotech, has signed a license agreement with Harvard University and a research collaboration agreement with...

Bluebird bio, a Cambridge, Massachusetts-based clinical-stage gene therapy company, has acquired a 125,000-square-foot manufacturing facility in Durham, North Carolina. Once construction and validation is complete, the site will produce lentiviral...

Lonza, Massachusetts Eye and Ear (MEE), a specialty hospital in Boston, Massachusetts, and Akouos, a Boston-based biotechnology company, have signed license agreements for exclusive rights to Lonza and MEE’s ancestral adeno-associated viral vectors...

LGM Pharma, a Nashville, Tennessee-headquartered active pharmaceutical ingredient (API) supplier, has received a majority equity investment from New Harbor Capital, a Chicago, Illinois-based private equity firm. LGM Pharma is involved in the...

AMRI, a contract research, development, and manufacturing organization, has more than doubled its current bulk active pharmaceutical ingredient (API) aseptic manufacturing capacity through the addition of a new multipurpose aseptic API line at its...

GE Healthcare has completed the acquisition of Puridify, a Stevenage, UK-headquartered bioprocessing start-up that is developing a nanofiber-based platform purification technology for biopharmaceutical production. Puridify has collaborated with...

Cytovance Biologics, an Oklahoma City, Oklahoma-based biologics contract manufacturer, has signed an agreement with Bexion Pharmaceuticals, a Covington, Kentucky-headquartered biotechnology company, to manufacture the protein component and active...

Brammer Bio, a Lexington, Massachusetts-headquartered cell and gene therapy contract development and manufacturing organization, has completed renovations and has launched its late-stage clinical capacity and commercial-ready cGMP manufacturing...

Recipharm, a Swedish contract development and manufacturing organization, has equipped three of its facilities with serialization capabilities in line with the US regulatory requirements. Its facilities in Brescia, Italy and Karlskoga and Uppsala,...